Koichi Kamei

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

Kazumoto Iijima, Mayumi Sako, Kandai Nozu et al. · The Lancet · 2014 · 443 citations

Medicine, Nephrology, Pediatrics +14

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

Koichi Kamei, Shuichi Ito, Kandai Nozu et al. · Pediatric Nephrology · 2009 · 175 citations

Medicine, Nephrology, Pediatrics +10

Rituximab in refractory nephrotic syndrome

Kazumoto Iijima, Koichi Kamei, Denis Geary et al. · Pediatric Nephrology · 2009 · 161 citations

Medicine, Nephrology, Pharmacotherapy +10

Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes

Eugene Yu-hin Chan, Hazel Webb, E. Yu et al. · Kidney International · 2019 · 118 citations

Medicine, Immunology, Nephrology +12

Rituximab for refractory focal segmental glomerulosclerosis

Makiko Nakayama, Koichi Kamei, Kandai Nozu et al. · Pediatric Nephrology · 2007 · 104 citations

Medicine, Nephrology, Pharmacotherapy +11